XYWAV Trademark

Trademark Overview

On Monday, July 29, 2019, a trademark application was filed for XYWAV with the United States Patent and Trademark Office. The USPTO has given the XYWAV trademark a serial number of 88546670. The federal status of this trademark filing is REGISTERED as of Tuesday, July 27, 2021. This trademark is owned by Jazz Pharmaceuticals, Inc.. The XYWAV trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for use in the treatment and/or management of sleep disorders and neurological disorders
xywav

General Information

Serial Number88546670
Word MarkXYWAV
Filing DateMonday, July 29, 2019
Status700 - REGISTERED
Status DateTuesday, July 27, 2021
Registration Number6435116
Registration DateTuesday, July 27, 2021
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 1, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for use in the treatment and/or management of sleep disorders and neurological disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, August 8, 2019
Primary Code005
First Use Anywhere DateFriday, October 2, 2020
First Use In Commerce DateFriday, October 2, 2020

Trademark Owner History

Party NameJazz Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressPalo Alto, CA 94306
Party NameJazz Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPalo Alto, CA 94304
Party NameJazz Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPalo Alto, CA 94304

Trademark Events

Event DateEvent Description
Thursday, August 1, 2019NEW APPLICATION ENTERED
Thursday, August 8, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, August 20, 2019ASSIGNED TO EXAMINER
Friday, August 23, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 11, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 1, 2019PUBLISHED FOR OPPOSITION
Tuesday, October 1, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 26, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, May 18, 2020SOU TEAS EXTENSION RECEIVED
Monday, May 18, 2020SOU EXTENSION 1 FILED
Monday, May 18, 2020SOU EXTENSION 1 GRANTED
Wednesday, May 20, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, November 27, 2020SOU TEAS EXTENSION RECEIVED
Friday, November 27, 2020SOU EXTENSION 2 FILED
Friday, November 27, 2020SOU EXTENSION 2 GRANTED
Tuesday, December 1, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 25, 2021TEAS STATEMENT OF USE RECEIVED
Friday, June 4, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, May 25, 2021USE AMENDMENT FILED
Saturday, June 5, 2021STATEMENT OF USE PROCESSING COMPLETE
Wednesday, June 23, 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, June 24, 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, July 27, 2021REGISTERED-PRINCIPAL REGISTER
Wednesday, October 30, 2024ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, November 11, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, November 11, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, November 11, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, November 11, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, November 11, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED

Related Keywords

xywav disorders pharmaceutical preparations sleep neurological management system acting central nervous